Journal article icon

Journal article

Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study

Abstract:
Extrafine, single-inhaler BDP/FF/G therapy was effective and safe in a routine clinical practice setting in a multi-national cohort of patients with moderate to severe asthma.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.2147/jaa.s582286

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-3890-7201
More by this author
Role:
Author
ORCID:
0000-0002-9305-9348


Publisher:
Taylor and Francis Group
Journal:
Journal of Asthma and Allergy More from this journal
Volume:
Volume 19
Pages:
1-21
Publication date:
2026-02-01
DOI:
EISSN:
1178-6965
ISSN:
1178-6965


Language:
English
Keywords:
Pubs id:
2383895
Local pid:
pubs:2383895
Source identifiers:
W7130528829
Deposit date:
2026-03-04
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP